Trends in Antibody-based Cancer Therapy
Trends in Antibody-based Cancer Therapy
Trends and challenges in one of the key areas of contemporary drug development - presented by industry professionals from leading pharmaceutical companies.
Part 1: THERAPEUTIC ANTIBODIES
Part 1: THERAPEUTIC ANTIBODIES
(1) Introduction: Trends in antibody-based therapy of cancer
(2) PD-1 and PD-L1 checkpoint inhibitory antibodies
Part 2: BISPECIFIC ANTIBODIES
(3) T cell bispecific antibodies for B and plasma cell malignancies
(4) Case study: Glofitamab for Non-Hodgkin lymphoma
(5) Case study: Teclistamab and talquetamab for Non-Hodgkin lymphoma
(6) Bispecific antibodies blocking receptor tyrosine kinases
(7) Bispecific antibodies for solid tumors
(8) Immunocytokines
Part 3: ANTIBODY-DRUG CONJUGATES
(9) Next generation antibody drug conjugates
(10) Discovery and development of Enhertu (trastuzumab deruxtecan)
Part 4: NEXT-GENERATION BISPECIFIC ANTIBODIES
(11) Antibody PROTACs
Klein, Christian
Lambert, John M.
Fischer, János
Childers, Wayne E.
Rotella, David P.
| ISBN | 9783527353842 |
|---|---|
| Media type | Book |
| Edition number | 1. Auflage |
| Copyright year | 2026 |
| Publisher | Wiley-VCH |
| Language | English |
